mRNA Beyond Vaccines: Programmable Therapeutics Explained
mRNA beyond vaccines — how programmable therapeutics work, lipid nanoparticle delivery, the manufacturing platform, and the real limits today.
How Heat Pumps Actually Work (and Why They Beat 100%)
How heat pumps actually work, explained — the refrigeration cycle, why COP can exceed 100% efficiency, cold-climate limits, and the real physics.
AlphaFold 3 and Protein Structure Prediction Explained
AlphaFold 3 explained — how the diffusion-based model predicts protein, DNA, and ligand structures, why it matters, and its real limitations.
How Lithium-Ion Batteries Work (and Why They Catch Fire)
How lithium-ion batteries work, explained — ions, cathodes, anodes, the SEI layer, and the chemistry of thermal runaway that makes them catch fire.
How Maglev Trains Actually Work: The Physics (2026)
2026 deep dive — how maglev trains actually levitate, propel, and steer: EMS vs EDS, SCMaglev superconductors, guidance, and why they're still niche.
Quantum Sensing in MRI: How SQUID Magnetometers Work (2026)
Research explainer 2026 — SQUID magnetometers and NV-center quantum sensors are quietly rewriting MRI and magnetoencephalography. How and why.
How GPS Atomic Clocks Actually Work: Precision Timekeeping
How GPS atomic clocks work in 2026 — rubidium and cesium oscillators, satellite timekeeping, relativity corrections, and PNT alternatives.
Geometric Deep Learning for Materials Discovery: GNoME, MatterGen, 2026 SOTA
Geometric deep learning for materials discovery in 2026 — GNoME, MatterGen, equivariant GNNs, the inverse design problem, and where ML-driven materials science actually ships.
How Atomic Clocks Actually Work: From Quantum Resonance to GPS
How atomic clocks actually work — cesium hyperfine transitions, optical lattice clocks, what makes them so accurate, and why GPS and the internet depend on them.
AlphaProteo: De Novo Protein Binder Design with AI
How DeepMind AlphaProteo designs de novo protein binders — diffusion + structure prediction, target-conditioning, in vitro hit rates, and the 2026 outlook for AI-designed therapeutics.